Skip to main content

Halcyon's Days May Have Ended

The technology blog GigaOm reports that DNA sequencing startup Halcyon Molecular has shut down. According to GigaOm, "sources familiar with the Redwood City, Calif.-based company say that it ran out of money."

As previously reported by Daily Scan's sister publication In Sequence, the company was developing a method for sequencing DNA that relied on stretching out single-stranded DNA molecules on a substrate and reading labeled bases by transmission electron microscopy.

The technology promised reads of at least 150 kilobases and as long as 4 megabases, with the ability to sequence a human genome to more than 99.9999-percent consensus accuracy and completeness in less than 10 minutes, at a cost of less than $100.

The firm was founded in 2003 by brothers Michael and William Andregg and received venture capital funding from the Founders Fund, and, in 2009, it was awarded $1.29 million in funding from the National Human Genome Research Institute. Additionally, in 2009, it received just over $244,000 under the Qualifying Therapeutic Discovery Project Program, created by the US Patient Protection and Affordable Care Act.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.